Laquinimod Sodium Salt
CAS: 248282-07-7
Ref. 3D-FL159548
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
Laquinimod Sodium Salt
Synonyms:
- N-Ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide sodium salt
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt (1:1)
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt
- Laquinimod sodium
- ABR 215062 sodium
Description:
Laquinimod is a quinoline derivative that is used as a pharmaceutical preparation. It has been shown to be a potent inhibitor of the cb1 receptor, which is responsible for the inflammatory response. Laquinimod also inhibits the phosphorylation of focal adhesion kinase (FAK) and prostaglandin E2 production in mice with colitis. The drug has been shown to have anti-inflammatory effects in several animal models of inflammatory diseases, such as collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), or chronic granulomatous disease.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
378.78 g/mol
Formula:
C19H16ClN2NaO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
